Control | DKD | DR | DPN | |
---|---|---|---|---|
N (%) | 364 (33.2%) | 426 (38.9%) | 274 (25.0%) | 359 (32.8%) |
Male | 242 (66.5%) | 317 (74.4%)* | 181 (64.1%) | 233 (64.9%) |
Age (years) | 48.50 ± 13.50 | 57.17 ± 12.55*** | 60.43 ± 10.86*** | 61.18 ± 10.47*** |
> 55 | 124 (34.1%) | 252 (59.2%)*** | 194 (70.8%)*** | 267 (74.4%)*** |
HbA1c (%) | 8.89 ± 2.43 | 8.54 ± 2.09 | 8.41 ± 2.13 | 8.29 ± 2.08 |
< 7 | 93 (25.5%) | 110 (25.8%) | 76 (27.7%) | 106 (29.5%) |
T2DM duration (years) | 5.43 ± 5.02 | 11.28 ± 7.32*** | 13.63 ± 7.21*** | 12.84 ± 6.72*** |
> 10 | 55 (15.1%) | 214 (50.2%)*** | 177 (64.6%)*** | 217 (60.4%)*** |
BMI (kg/m2) | 26.02 ± 4.05 | 26.39 ± 3.65 | 25.55 ± 3.35 | 25.69 ± 3.55 |
< 24 | 262 (72.0%) | 313 (73.5%) | 182 (66.4%) | 237 (66.0%) |
Hypertension | 93 (25.5%) | 273 (64.1%)*** | 176 (64.2%)*** | 186 (51.8%)*** |
Lipid profile (mmol/L) | ||||
TC | 4.34 ± 0.92 | 4.65 ± 1.25*** | 4.49 ± 1.29 | 4.31 ± 1.12 |
TG | 2.10 ± 1.36 | 2.50 ± 1.76*** | 2.21 ± 1.35 | 2.12 ± 1.33 |
HDL-C | 1.11 ± 0.30 | 1.04 ± 0.27** | 1.06 ± 0.54 | 1.05 ± 0.50 |
LDL-C | 2.61 ± 0.87 | 2.57 ± 1.02 | 2.42 ± 1.03 | 2.36 ± 0.92 |
Dyslipidemia | 226 (62.1%) | 378 (88.7%)*** | 246 (89.8%)*** | 324 (90.3%)*** |
High TC | 18 (4.9%) | 46 (10.8%)* | 25 (9.1%)* | 18 (5.0%) |
High TG | 94 (25.8%) | 197 (46.2%)*** | 122 (44.5%)*** | 144 (40.1%)*** |
Low HDL-C | 152 (41.8%) | 240 (56.3%)*** | 160 (58.4%)*** | 212 (59.1%)*** |
High LDL-C | 11 (3.0%) | 24 (5.6%) | 14 (5.1%) | 14 (3.9%) |